Whitaker Raymond J 4

4 · FLUIDIGM CORP · Filed Feb 17, 2011

Form 4

Period: 2011-02-15

Director

Transactions

Conversion
Common Stock
2011-02-15+320,063→ 801,917 total(indirect: See Footnotes)
Conversion
Common Stock
2011-02-15+66,991→ 868,908 total(indirect: See Footnotes)
Conversion
Series E Preferred Stock
2011-02-15−47,400→ 821,508 total(indirect: See Footnotes)
→ Common Stock (47,400 underlying)
Conversion
Series C Preferred Stock
2011-02-15−320,063→ 66,991 total(indirect: See Footnotes)
→ Common Stock (320,063 underlying)
Conversion
Series D Preferred Stock
2011-02-15−66,991→ 0 total(indirect: See Footnotes)
→ Common Stock (66,991 underlying)
Conversion
Common Stock
2011-02-15+47,400→ 47,400 total(indirect: See Footnotes)
Conversion
Common Stock
2011-02-15+320,063→ 367,463 total(indirect: See Footnotes)
Conversion
Common Stock
2011-02-15+47,400→ 481,854 total(indirect: See Footnotes)
Conversion
Common Stock
2011-02-15+66,991→ 434,454 total(indirect: See Footnotes)
Conversion
Series C Preferred Stock
2011-02-15−320,063→ 501,445 total(indirect: See Footnotes)
→ Common Stock (320,063 underlying)
Conversion
Series D Preferred Stock
2011-02-15−66,991→ 434,454 total(indirect: See Footnotes)
→ Common Stock (66,991 underlying)
Conversion
Series E Preferred Stock
2011-02-15−47,400→ 387,054 total(indirect: See Footnotes)
→ Common Stock (47,400 underlying)

Footnotes (8)

[F1]Represents shares of Common Stock issued upon conversion of shares of Series E Preferred Stock on a 1-for-1.300053676865 basis.
[F2]Not applicable.
[F3]EuclidSR Partners, L.P., is the record holder of the securities reported.
[F4]Mr. Whitaker, the reporting person, is a member of the Board of Directors of the Issuer and shares voting and investment power with Graham D.S. Anderson, Milton J. Pappas and Stephen K. Reidy, each of whom is a general partner of EuclidSR Associates, L.P., the general partner of EuclidSR Partners, L.P. Mr. Whitaker and each of the other general partners of EuclidSR Associates, L.P. discliams beneficial ownership of these securities except to the extent of his pecuniary interest therein.
[F5]Represents shares of Common Stock issued upon the conversion of shares of Series C Preferred Stock or Series D Preferred Stock on a 1-for-1 basis.
[F6]EuclidSR Biotechnology Partners, L.P. is the record holder of the securities reported.
[F7]Each share of Series E Preferred Stock automatically converted into 1.300053676865 share of Common Stock on February 15, 2011, the closing date of the Issuer's initial public offering (the "Closing") and has no expiration date.
[F8]Each share of Series C Preferred Stock or Series D Preferred Stock automatically converted into one share of Common Stock on the Closing and has no expiration date.

Documents

1 file